Trials / Completed
CompletedNCT02293564
Open-label Safety Extension Study of Gevokizumab in Erosive Osteoarthritis of the Hand
An Open-label Safety Extension Study of Gevokizumab in Active Inflammatory, Erosive Osteoarthritis of the Hand
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 312 (actual)
- Sponsor
- XOMA (US) LLC · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the long-term safety of gevokizumab in the treatment of active inflammatory, erosive osteoarthritis of the hand.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | gevokizumab | Solution for subcutaneous injection |
Timeline
- Start date
- 2013-03-01
- Primary completion
- 2015-01-01
- First posted
- 2014-11-18
- Last updated
- 2015-02-19
Locations
28 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02293564. Inclusion in this directory is not an endorsement.